| 产品详情 |
| Edit |   |
| Product Name | FATP2 Inhibitor, CB-2 |
| Description | Purity ~99% (HPLC). A cell permeable thioxothiazolindine compound that reversibly inhibits FATP2-mediated long chain fatty acid uptake in Caco-2 and HepG2, but not non-FATP2-expressing 3T3-L1 adipocytes, cultures (IC50 = 3.99, 7.55, and 231.1uM, respectively), while exhibiting much reduced potency toward cellular Acsl (acyl-CoA synthetase) activity (IC50 = 50uM). Shown not to affect Caco-2 viability, membrane permeability, or glucose transport. Primary Target IC50: 8u Solubility: DMSO |
| Size | 10mg |
| Concentration | n/a |
| Applications | n/a |
| Other Names | FATP2 Inhibitor, CB-2 (Fatty Acid Transport Protein 2 Inhibitor, (5E)-5-((3-bromo-4-hydroxy-5-methoxyphenyl)methylene)-3-(3-chlorophenyl)-2-thioxothiazolidin-4-one, CB2) |
| Gene, Accession, CAS # | n/a |
| Catalog # | 217353 |
| Price | |
| Order / More Info | FATP2 Inhibitor, CB-2 from UNITED STATES BIOLOGICAL |
| Product Specific References | n/a |
| 产品资料 |
|
|